Showing results (81-90 of 428) with videos related to
Sort By:
Pageof 43
Nature Chemical Biology|October 19, 2017
Discovery of new GPCR ligands to illuminate new biologyBryan L Roth, John J Irwin, Brian K ShoichetPsychopharmacology|June 19, 2004
Serotonin receptors represent highly favorable molecular targets for cognitive enhancement in schizophrenia and other disordersBryan L Roth, S Mohammad Hanizavareh, Andrew E BlumJournal of Medicinal Chemistry|April 28, 2012
Chemocentric informatics approach to drug discovery: identification and experimental validation of selective estrogen receptor modulators as ligands of 5-hydroxytryptamine-6 receptors and as potential cognition enhancersRima Hajjo, Vincent Setola, Bryan L Roth, et al.Current Opinion in Cell Biology|April 1, 2014
Tuning up the right signal: chemical and genetic approaches to study GPCR functionsPatrick M Giguere, Wesley K Kroeze, Bryan L RothJournal of Neurochemistry|November 19, 2021
Molecular insights into psychedelic drug actionSamuel T Slocum, Jeffrey F DiBerto, Bryan L RothThe Journal of Biological Chemistry|April 29, 2015
An Iron Reservoir to the Catalytic Metal: THE RUBREDOXIN IRON IN AN EXTRADIOL DIOXYGENASEFange Liu, Jiafeng Geng, Ryan H Gumpper, et al.Bioinformatics (Oxford, England)|December 31, 2013
HTS navigator: freely accessible cheminformatics software for analyzing high-throughput screening dataDenis Fourches, Maria F Sassano, Bryan L Roth, et al.Pharmacological Reviews|September 26, 2019
Harnessing Ion-Binding Sites for GPCR PharmacologyBarbara Zarzycka, Saheem A Zaidi, Bryan L Roth, et al.Molecular Pharmacology|April 16, 2005
Molecular determinants for the interaction of the valvulopathic anorexigen norfenfluramine with the 5-HT2B receptorVincent Setola, Malgorzata Dukat, Richard A Glennon, et al.Bioorganic & Medicinal Chemistry Letters|September 2, 2006
Interaction of N1-unsubstituted and N1-benzenesulfonyltryptamines at h5-HT6 receptorsRenata Kolanos, Małgorzata Dukat, Bryan L Roth, et al.Pageof 43